PubMed Health⌕ Search

PubMed · 12495143

Testing mutual independence between two discrete-valued spatial processes: a correction to pearson chi-squared.

Abstract

A common feature of data collected in environmental and earth sciences is that they typically exhibit spatial autocorrelation. Violating the assumption of independent observations can have dramatic effects on inferences derived from standard statistical methods. In this article, we examine the consequences of spatial autocorrelation on Pearson's chi-squared test of mutual independence between two categorical responses with a general number of classes. Correspondingly, we suggest a simple modification to the standard test statistic that allows for spatial autocorrelation. Our modified statistic is based on a first-order correction factor and thus provides only an approximate test. However, we show by Monte Carlo simulation that this approximation results in satisfactory inferences in several situations of practical interest. The usefulness of the method is displayed through an application to categorical data arising in the study of the relationship between the distribution pattern of plant species and woodland age in a forest in northern Belgium.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Andrea Cerioli. 2002. Testing mutual independence between two discrete-valued spatial processes: a correction to pearson chi-squared.. https://doi.org/10.1111/j.0006-341x.2002.00888.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The future of precision oncology and artificial intelligence in Belgium: scenarios and policy responses.

PURPOSE: Precision medicine, also known as personalized medicine, enables the provision of tailored health services to patients. In the prevention, early detection, and treatment of cancers, precision medicine is highly promising, given the increasing use of genomic profiling for diagnosis and adapting therapies in several tumor types. Artificial Intelligence (AI) can support this process by analyzing vast amounts of relevant data. However, high-quality data and financial investments in the health system are essential for the implementation of precision medicine and AI solutions in routine cancer care. DESIGN/METHODOLOGY/APPROACH: Building on the quantitative outcomes of a foresight exercise published in another study, this article collects qualitative data to gain more detailed insights into the future of precision oncology in Belgium and discusses the role of AI in this field. It reports the results of a series of expert workshops, focusing on four hypothetical future scenarios that are centered around technological and economic issues that must be overcome for the widespread use of precision oncology in Belgium. FINDINGS: The study concludes that all four scenarios discussed in the workshops would require supportive policy measures in Belgium, which should go beyond mere technological and economic considerations, such as involving patient associations and the public in policy design or creating multi-disciplinary expert groups for precision medicine. ORIGINALITY/VALUE: To the best of our knowledge, this is the first study to employ foresight methodology to illustrate possible future scenarios, scrutinize feasible approaches for implementing precision oncology in Belgium, and discuss the use of AI in this context.

Belgium↗